EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence

Beni Jequicene Mussengue Chaúque iD, Luiza Bernardes Chagas iD, Thaisla Cristiane Borella da Silva, Denise Leal Dos Santos, Luciano Palmeiro Rodrigues iD, Lucile da Silva Lins Baía, Manoella Kessler Gomes Rodrigues, Guilherme Brittes Benitez iD, Thais Lemos Mendes, Hellen Kempfer Philippsen iD, Luciana Dalla Rosa, Fabrício Souza Campos iD und 3 weitere

Pathogens · 2026

DOI: 10.3390/pathogens15030294 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pathogens, 2026. Verfasst von Beni Jequicene Mussengue Chaúque und 14 weiteren Autor:innen. Beteiligte Einrichtung: Master's Program in Clinical Research, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, RS, Brazil. Hauptthemen laut MEDLINE: Drug Repositioning, Amebiasis, Amebicides, Antiprotozoal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Resources Training Project to Support the Development of Clinical Research in Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Devastating or nearly invariably fatal infections caused by free-living amoebae (FLA), including Acanthamoeba keratitis (AK), granulomatous amoebic encephalitis (GAE), and primary amoebic meningoencephalitis (PAM), remain a significant public health concern, driven by increasing case numbers, geographic expansion, and the lack of approved, effective, and safe treatments. Despite decades of research, no new drugs have been successfully approved, highlighting the severe limitations of de novo drug development for these infections, particularly for GAE and PAM, largely due to the challenges of conducting clinical trials for these rare and rapidly lethal diseases. In this context, drug repurposing represents a cost-effective and promising strategy to accelerate therapeutic advances and overcome key bottlenecks of conventional drug development. Accordingly, we conducted a systematic review of in vitro studies and animal models of AK, GAE, and PAM reported in indexed databases to identify promising drug repurposing candidates against FLA infections. After screening 23,624 records, 112 studies were included in the analysis. Overall, 2726 drugs and drug combinations, spanning 865 pharmacological classes and approved for 565 therapeutic indications, were assessed for their repurposing potential. Among these, 166 compounds showed substantial trophocidal activity (≥IC50) at potentially translatable concentrations (≤10 µM), including six with additional cysticidal activity. In vitro, four compounds were active against Balamuthia mandrillaris, 44 against Acanthamoeba spp. (three cysticidal), and 115 against Naegleria spp. (three cysticidal). In in vivo studies, sulfadiazine and rifampicin were effective as preventive or early monotherapies for GAE. For AK, the combination of polyhexamethylene biguanide, neomycin, and atropine, as well as voriconazole and nitazoxanide monotherapies, showed the greatest promise. In PAM, azithromycin alone or in combination with amphotericin B emerged as the most promising therapeutic options. Further studies are required to advance the clinical translatability of these findings. To the best of our knowledge, this work provides the first comprehensive and integrated synthesis of repurposable drug candidates against FLA infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAmebiasisAmebicidesAntiprotozoal AgentsAmoebaHumansAnimalsAcanthamoeba KeratitisAcanthamoeba

Stichwörter der Autor:innen

Acanthamoeba keratitisdrug repurposinggranulomatous amoebic encephalitisin vitroin vivoprimary amoebic meningoencephalitis

Substanzen

AmebicidesAntiprotozoal Agents

Autor:innen und Institutionen

  • Master's Program in Clinical Research, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, RS, Brazil.
  • Postgraduate Program in Biological Sciences-Pharmacology and Therapeutics, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.
  • Center of Studies in Science and Technology (NECET), Biology Course, Universidade Rovuma, Lichinga P.O. Box 04, Niassa, Mozambique.
  • Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.
  • Protozoology Laboratory, Microbiology Immunology and Parasitology Department, Basic Health Sciences Institute, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.
  • Physiotherapy Course, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.

ORCID-Profile: Beni Jequicene Mussengue Chaúque, Luiza Bernardes Chagas, Luciano Palmeiro Rodrigues, Guilherme Brittes Benitez, Hellen Kempfer Philippsen, Fabrício Souza Campos, Régis Adriel Zanette, José Roberto Goldim

Förderung

  • Human Resources Training Project to Support the Development of Clinical Research in Brazil

Zitieren

APA

Chaúque, B. J. M., Chagas, L. B., da Silva, T. C. B., Dos Santos, D. L., Rodrigues, L. P., Baía, L. D. S. L., Rodrigues, M. K. G., Benitez, G. B., Mendes, T. L., Philippsen, H. K., Rosa, L. D., Campos, F. S., Rott, M. B., Zanette, R. A., & Goldim, J. R. (2026). Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence. Pathogens. https://doi.org/10.3390/pathogens15030294

Vancouver

Chaúque BJM, Chagas LB, da Silva TCB, Dos Santos DL, Rodrigues LP, Baía LDSL, et al. Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence. Pathogens. 2026. doi:10.3390/pathogens15030294

BibTeX
@article{Chaque2026,
  author = {Chaúque, Beni Jequicene Mussengue and Chagas, Luiza Bernardes and da Silva, Thaisla Cristiane Borella and Dos Santos, Denise Leal and Rodrigues, Luciano Palmeiro and Baía, Lucile da Silva Lins and Rodrigues, Manoella Kessler Gomes and Benitez, Guilherme Brittes and Mendes, Thais Lemos and Philippsen, Hellen Kempfer and Rosa, Luciana Dalla and Campos, Fabrício Souza and Rott, Marilise Brittes and Zanette, Régis Adriel and Goldim, José Roberto},
  title = {Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15030294}
}
Kostenlos starten →